The alternative and complementary medicine sector is rapidly changing: the urgent need to professionalize with federally regulated qualifications and practices.
The page features four people at Biopôle who transitioned from academic institutions to industry and discusses their journeys, challenges, and lessons.
Regenerative medicine aims to repair, replace, or regenerate human cells, tissues, or organs to restore normal function. It includes approaches that use the body’s healing capabilities to treat conditions.
Abionic announced completion of a multicenter observational study of its point-of-care Pancreatic Stone Protein (PSP) sepsis test on the abioSCOPE platform.
Association BioAlps held its annual flagship event on October 29, 2019, at Théâtre du Crochetan in Monthey. The event focused on health and technology professions of tomorrow in the Health Valley.
Cellestia Biotech AG was selected for a CHF 2 million grant from Innosuisse to advance a therapy for preventing Graft vs Host Disease to clinical proof of concept.
